metaLead develops innovative solutions to safely and effectively treat metal poisoning.
Location: Switzerland, Zurich
Employees: 1-10
Total raised: $1.21M
Investors 2
| Date | Name | Website |
| 08.04.2023 | Venture Ki... | venturekic... |
| 25.03.2024 | VentureLab | venturelab... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 06.05.2025 | - | $1.21M | - |
Mentions in press and media 11
| Date | Title | Description |
| 31.10.2025 | More than 20 Swiss biotech companies to exhibit at Bio Europe | Bio-Europe, the leading partnering conference for the global biotechnology industry, is held annually to connect biotech, pharma, investors, and service providers through one-to-one meetings, presentations, and panels. It serves as a leadi... |
| 15.10.2025 | Industry veterans join Lifesciences and fashion-tech startups | MetaLead Therapeutics, a spinoff of the University of Zurich, has developed a novel metal-binding peptide platform to create best-in-class therapeutics that target pathological metals, restore healthy balance, or deliver therapeutic counte... |
| 06.05.2025 | MetaLead's Bold Leap: A New Dawn for Wilson Disease Treatment | In the heart of Zurich, a quiet revolution is brewing. MetaLead Therapeutics, a promising biotech startup, has secured CHF 1 million to tackle a silent killer: Wilson disease. This genetic disorder causes copper to accumulate in the body, l... |
| 06.05.2025 | MetaLead Secures CHF 1M to advance treatment for Wilson's disease | MetaLead Therapeutics, a spin-off from the University of Zurich, is developing a new class of metal-binding drugs aimed at overcoming the shortcomings of existing chelation therapies. Its proprietary peptide-based platform offers greater se... |
| 06.05.2025 | metaLead secures CHF 1 million to tackle metal poisoning | Aiming to offer a more effective and well-tolerated alternative to existing chelation therapies, Zurich-based startup metaLead developed a proprietary peptide-based therapeutic platform designed to identify and optimize short novel peptidi... |
| 06.12.2024 | BaseLaunch supports the development of therapies for metal- and age-related diseases | MetaLead Therapeutics AG and MT-act along with three companies in stealth mode have been enrolled in the BaseLaunch incubation program, a Basel-based biotech accelerator and incubator that helps scientists and entrepreneurs launch and grow... |
| 08.11.2024 | Bio-Europe: Switzerland's Biotech Showcase in Stockholm | The heart of Europe beats strong in Stockholm this November. Bio-Europe, the continent's premier partnering event for the life sciences, is back for its 30th edition. This year, it promises to be a melting pot of innovation, collaboration, ... |
| 05.11.2024 | Bio Europe in Stockholm hosts 33 Swiss companies | Currently in its 30-year-edition, BIO-Europe remains Europe's leading partnering event, for the life sciences ecosystem, providing an exceptional opportunity to explore the latest trends learn and connect with potential partners. The past ... |
| 29.12.2023 | Recognition for the novel solutions | |
| 22.05.2023 | Top 18 startups in the >>venture>> competition proceed to the next round |
Show more